NDC 50474-781 – Bimzelx

Bimekizumab 160 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC50474-781

Product details

Brand name
Bimzelx
Generic name
Bimekizumab
Labeler
UCB, Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761151
Marketed since
October 17, 2023
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Bimzelx →

Package NDC codes (4)

Package NDCDescriptionSince
50474-781-841 SYRINGE, GLASS in 1 CARTON (50474-781-84) / 1 mL in 1 SYRINGE, GLASSOct 1, 2024
50474-781-852 SYRINGE, GLASS in 1 CARTON (50474-781-85) / 1 mL in 1 SYRINGE, GLASSOct 17, 2023
50474-781-861 SYRINGE, GLASS in 1 CARTON (50474-781-86) / 1 mL in 1 SYRINGE, GLASSOct 1, 2024
50474-781-872 SYRINGE, GLASS in 1 CARTON (50474-781-87) / 1 mL in 1 SYRINGE, GLASSOct 17, 2023

Other Bimzelx products